Snapshot img

Healthcare Information Systems Market Size 2024-2028

The healthcare information systems market size is forecast to increase by USD 126.2 billion at a CAGR of 9.5% between 2023 and 2028.

The market is experiencing significant growth due to the increasing demand for efficient medical care and disease management. Key features of HIS, such as medical device integration and ease of use, are driving this growth. Remote patient monitoring and disease management are becoming increasingly important, enabling healthcare providers to deliver better patient care and financial savings through improved efficiency. However, technical considerations, including data security and privacy, remain challenges that must be addressed to ensure the successful implementation and adoption of HIS. The market is witnessing a high demand for electronic health record (EHR) solutions and an increasing number of mergers and acquisitions. Despite these opportunities, it is crucial for providers to carefully consider the technical aspects of HIS implementation to ensure seamless integration and optimal performance.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The healthcare industry is undergoing a significant transformation, driven by advancements in technology and the increasing demand for efficient, patient-centric care. The market is witnessing substantial growth as healthcare organizations seek to optimize their operations, improve patient outcomes, and reduce costs. Healthcare data management is a critical component of this transformation. The ability to collect, store, and analyze large volumes of patient data is essential for delivering personalized and precise medical care. Healthcare data analytics is playing an increasingly important role in this regard, enabling healthcare providers to gain valuable insights from patient data and make informed decisions.
In addition, another key trend in the market is healthcare data security. With the increasing digitization of healthcare data, ensuring its security and privacy is a top priority. Healthcare organizations are investing in advanced cybersecurity solutions to protect sensitive patient information from cyber threats. Mobile technology is also transforming the healthcare landscape. Mobile health apps, telehealth platforms, and wearable technology are enabling remote patient monitoring, teleconsultations, and other innovative healthcare services. These technologies are improving patient engagement, enhancing the patient experience, and reducing the need for in-person visits. Cloud-based healthcare systems are another area of growth in the market.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Revenue cycle management
  Hospital information system
  Medical imaging information system
  Pharmacy information systems
  Laboratory information systems


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Application Insights

The revenue cycle management segment is estimated to witness significant growth during the forecast period.

The healthcare industry's shift towards digitalization is driving the adoption of Healthcare Information Systems (HCIS), particularly in patient engagement and managing patient-related data. Chronic diseases, which account for a significant portion of healthcare expenditures, necessitate effective data management and analysis. HCIS product lines, including hardware and healthcare IT solutions, enable healthcare facilities to streamline operations, reduce costs, and enhance patient care. As the US population ages and the prevalence of chronic diseases increases, the need for advanced healthcare data analytics becomes more critical. HCIS solutions help manage complex billing processes, ensuring accuracy and compliance with regulations such as HIPAA and FDCPA.

Get a glance at the market report of share of various segments Request Free Sample

The revenue cycle management segment was valued at USD 81.10 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 47% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

In North America, the market is among the most advanced, driven by substantial investments in healthcare and government initiativ

Snapshot img

Healthcare Analytics Market Size 2025-2029

The healthcare analytics market size is forecast to increase by USD 81.28 billion, at a CAGR of 25% between 2024 and 2029.

The market is experiencing significant growth due to several key trends. The integration of big data with healthcare analytics is a major growth factor, enabling healthcare providers to make data-driven decisions and improve patient outcomes.
Another trend is the increasing use of Internet-enabled mobile devices in healthcare services, allowing for remote monitoring and real-time data access. However, data security and privacy concerns remain a challenge, with the need for strong security measures to protect sensitive patient information. These trends are shaping the future of patient engagement and driving growth in the global healthcare analytics market as well.

What will be the Size of the Healthcare Analytics Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to the increasing adoption of digital solutions for improving patient care and reducing treatment costs. Healthcare organizations are leveraging descriptive analytics to gain insights from clinical data, while predictive and prescriptive analytics enable the development of personalized treatment plans and optimal therapeutic strategies. Financial analytics help manage healthcare expenses, ensuring cost-effective patient care. The National Institutes of Health (NIH) and other research institutions are driving innovation in health data analytics, leading to advancements in areas such as patient compliance, medication selection, and disease management. Industry leaders are utilizing artificial intelligence and machine learning to enhance clinical care, outreach, and disease management, ultimately leading to better treatment consistency and optimal outcomes for patients.

How is this Healthcare Analytics Industry segmented and which is the largest segment?

The healthcare analytics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Services
  Software
  Hardware


Deployment

  On-premise
  Cloud-based


Type

  Descriptive Analysis
  Predictive Analysis
  Prescriptive and Diagnostics


Application

  Financial Analytics
  Clinical Analytics
  Operations and Administrative Analytics
  Population Health Analytics


End-User

  Insurance Company
  Government Agencies
  Healthcare Providers
  Pharmaceutical and Medical Device Companies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  South America



  Middle East and Africa

By Component Insights

The services segment is estimated to witness significant growth during the forecast period. Healthcare analytics services encompass consulting, learning and training, development and integration, hardware maintenance and support, IT management, process management, and software support. The consulting and software support segments are experiencing significant growth due to the increasing demand for advanced healthcare delivery systems and cost-effective models. The healthcare sector's ongoing transition from on-premises to cloud-based software and IT infrastructure deployment is another growth driver. This shift is expected to increase the demand for IT education and training services. End-users of these services range from individual doctor offices to full-service hospitals and multi-location clinics, including large hospitals and tissue and blood processing organizations.

Get a glance at the share of various segments. Request Free Sample

The services segment was valued at USD 6.7 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

APAC is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market is driven by the increasing demand for secure data access and effective patient information management. The US and Canada are the primary contributors to this market due to their early adoption of advanced technologies, such as machine learning, predictive analytics, and quantum computing, across various industries. These technologies enable the healthcare sector to optimize patient compliance, medication selection, and therapeutic strategies and, ultimately, achieve optimal outcomes. Major companies in this market provide solutions to help healthcare organizations manage and

This table presents a wide variety of historical data in the field of health, lifestyle and health care. Figures on births and mortality, causes of death and the occurrence of certain infectious diseases are available from 1900, other series from later dates. In addition to self-perceived health, the table contains figures on infectious diseases, hospitalisations per diagnosis, life expectancy, lifestyle factors such as smoking, alcohol consumption and obesity, and causes of death. The table also gives information on several aspects of health care, such as the number of practising professionals, the number of available hospital beds, nursing day averages and the expenditures on care. Many subjects are also covered in more detail by data in other tables, although sometimes with a shorter history. Data on notifiable infectious diseases and HIV/AIDS are not included in other tables. Data available from: 1900 Status of the figures: 2024: The available figures are definite. 2023: Most available figures are definite. Figures are provisional for: occurrence of infectious diseases; expenditures on health and welfare; perinatal and infant mortality. 2022: Most available figures are definite. Figures are provisional for: occurrence of infectious diseases; diagnoses at hospital admissions; number of hospital discharges and length of stay; number of hospital beds; health professions; expenditures on health and welfare. 2021: Most available figures are definite. Figures are provisional for: occurrence of infectious diseases; expenditures on health and welfare. 2020 and earlier: Most available figures are definite. Due to 'dynamic' registrations, figures for notifiable infectious diseases, HIV, AIDS remain provisional. Changes as of 18 december 2024: Due to a revision of the statistics Health and welfare expenditure 2021, figures for expenditure on health and welfare have been replaced from 2021 onwards. Revised figures on the volume index of healthcare costs are not yet available, these figures have been deleted from 2021 onwards. The most recent available figures have been added for: live born children, deaths; occurrence of infectious diseases; number of hospital beds; expenditures on health and welfare; perinatal and infant mortality; healthy life expectancy; causes of death. When will new figures be published? July 2025.

Update — December 7, 2014. – Evidence-based medicine (EBM) is not working for many reasons, for example: 1. Incorrect in their foundations (paradox): hierarchical levels of evidence are supported by opinions (i.e., lowest strength of evidence according to EBM) instead of real data collected from different types of study designs (i.e., evidence). http://dx.doi.org/10.6084/m9.figshare.1122534 2. The effect of criminal practices by pharmaceutical companies is only possible because of the complicity of others: healthcare systems, professional associations, governmental and academic institutions. Pharmaceutical companies also corrupt at the personal level, politicians and political parties are on their payroll, medical professionals seduced by different types of gifts in exchange of prescriptions (i.e., bribery) which very likely results in patients not receiving the proper treatment for their disease, many times there is no such thing: healthy persons not needing pharmacological treatments of any kind are constantly misdiagnosed and treated with unnecessary drugs. Some medical professionals are converted in K.O.L. which is only a puppet appearing on stage to spread lies to their peers, a person supposedly trained to improve the well-being of others, now deceits on behalf of pharmaceutical companies. Probably the saddest thing is that many honest doctors are being misled by these lies created by the rules of pharmaceutical marketing instead of scientific, medical, and ethical principles. Interpretation of EBM in this context was not anticipated by their creators. “The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs.” ―Peter C. Gøtzsche “doctors and their organisations should recognise that it is unethical to receive money that has been earned in part through crimes that have harmed those people whose interests doctors are expected to take care of. Many crimes would be impossible to carry out if doctors weren’t willing to participate in them.” —Peter C Gøtzsche, The BMJ, 2012, Big pharma often commits corporate crime, and this must be stopped. Pending (Colombia): Health Promoter Entities (In Spanish: EPS ―Empresas Promotoras de Salud).

1. Misinterpretations New technologies or concepts are difficult to understand in the beginning, it doesn’t matter their simplicity, we need to get used to new tools aimed to improve our professional practice. Probably the best explanation is here in these videos (credits to Antonio Villafaina for sharing these videos with me). English https://www.youtube.com/watch?v=pQHX-SjgQvQ&w=420&h=315 Spanish https://www.youtube.com/watch?v=DApozQBrlhU&w=420&h=315 ----------------------- Hypothesis: hierarchical levels of evidence based medicine are wrong Dear Editor, I have data to support the hypothesis described in the title of this letter. Before rejecting the null hypothesis I would like to ask the following open question:Could you support with data that hierarchical levels of evidence based medicine are correct? (1,2) Additional explanation to this question: – Only respond to this question attaching publicly available raw data.– Be aware that more than a question this is a challenge: I have data (i.e., evidence) which is contrary to classic (i.e., McMaster) or current (i.e., Oxford) hierarchical levels of evidence based medicine. An important part of this data (but not all) is publicly available. References
2. Ramirez, Jorge H (2014): The EBM challenge. figshare. http://dx.doi.org/10.6084/m9.figshare.1135873
3. The EBM Challenge Day 1: No Answers. Competing interests: I endorse the principles of open data in human biomedical research Read this letter on The BMJ – August 13, 2014.http://www.bmj.com/content/348/bmj.g3725/rr/762595Re: Greenhalgh T, et al. Evidence based medicine: a movement in crisis? BMJ 2014; 348: g3725. _ Fileset contents Raw data: Excel archive: Raw data, interactive figures, and PubMed search terms. Google Spreadsheet is also available (URL below the article description). Figure 1. Unadjusted (Fig 1A) and adjusted (Fig 1B) PubMed publication trends (01/01/1992 to 30/06/2014). Figure 2. Adjusted PubMed publication trends (07/01/2008 to 29/06/2014) Figure 3. Google search trends: Jan 2004 to Jun 2014 / 1-week periods. Figure 4. PubMed publication trends (1962-2013) systematic reviews and meta-analysis, clinical trials, and observational studies.
   Figure 5. Ramirez, Jorge H (2014): Infographics: Unpublished US phase 3 clinical trials (2002-2014) completed before Jan 2011 = 50.8%. figshare.http://dx.doi.org/10.6084/m9.figshare.1121675 Raw data: "13377 studies found for: Completed | Interventional Studies | Phase 3 | received from 01/01/2002 to 01/01/2014 | Worldwide". This database complies with the terms and conditions of ClinicalTrials.gov: http://clinicaltrials.gov/ct2/about-site/terms-conditions Supplementary Figures (S1-S6). PubMed publication delay in the indexation processes does not explain the descending trends in the scientific output of evidence-based medicine. Acknowledgments I would like to acknowledge the following persons for providing valuable concepts in data visualization and infographics:
4. Maria Fernanda Ramírez. Professor of graphic design. Universidad del Valle. Cali, Colombia.
5. Lorena Franco. Graphic design student. Universidad del Valle. Cali, Colombia. Related articles by this author (Jorge H. Ramírez)
6. Ramirez JH. Lack of transparency in clinical trials: a call for action. Colomb Med (Cali) 2013;44(4):243-6. URL: http://www.ncbi.nlm.nih.gov/pubmed/24892242
7. Ramirez JH. Re: Evidence based medicine is broken (17 June 2014). http://www.bmj.com/node/759181
8. Ramirez JH. Re: Global rules for global health: why we need an independent, impartial WHO (19 June 2014). http://www.bmj.com/node/759151
9. Ramirez JH. PubMed publication trends (1992 to 2014): evidence based medicine and clinical practice guidelines (04 July 2014). http://www.bmj.com/content/348/bmj.g3725/rr/759895 Recommended articles
10. Greenhalgh Trisha, Howick Jeremy,Maskrey Neal. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725
11. Spence Des. Evidence based medicine is broken BMJ 2014; 348:g22
12. Schünemann Holger J, Oxman Andrew D,Brozek Jan, Glasziou Paul, JaeschkeRoman, Vist Gunn E et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 2008; 336:1106
13. Lau Joseph, Ioannidis John P A, TerrinNorma, Schmid Christopher H, OlkinIngram. The case of the misleading funnel plot BMJ 2006; 333:597
14. Moynihan R, Henry D, Moons KGM (2014) Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much. PLoS Med 11(7): e1001655. doi:10.1371/journal.pmed.1001655
15. Katz D. A-holistic view of evidence based medicinehttp://thehealthcareblog.com/blog/2014/05/02/a-holistic-view-of-evidence-based-medicine/ ---

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org. This dataset contains the annual number and percent of live births by the trimester in which the mother began prenatal care, with corresponding 95% confidence intervals, by Chicago community area, for the years 1999 – 2009. See full description at http://bit.ly/KcmIg2

United Healthcare Transparency in Coverage Dataset

Unlock the power of healthcare pricing transparency with our comprehensive United Healthcare Transparency in Coverage dataset. This invaluable resource provides unparalleled insights into healthcare costs, enabling data-driven decision-making for insurers, employers, researchers, and policymakers.

Key Features:

• Extensive Coverage: Access detailed pricing information for a wide range of medical procedures and services across the United States, covering approximately 76,000 employers.
• Granular Data: Analyze costs at the provider, plan, and employer levels, allowing for in-depth comparisons and trend analysis.
• Massive Scale: Over 400TB of data generated monthly, providing a wealth of information for comprehensive analysis.
• Historical Perspective: Track pricing changes over time to identify patterns and forecast future trends.
• Regular Updates: Stay current with the latest pricing information, ensuring your analyses are always based on the most recent data.

Detailed Data Points:

For each of the 76,000 employers, the dataset includes: 1. In-network negotiated rates for covered items and services 2. Historical out-of-network allowed amounts and billed charges 3. Cost-sharing information for specific items and services 4. Pricing data for medical procedures and services across providers, plans, and employers

Use Cases

For Insurers: - Benchmark your rates against competitors - Optimize network design and provider contracting - Develop more competitive and cost-effective insurance products

For Employers: - Make informed decisions about health plan offerings - Negotiate better rates with insurers and providers - Implement cost-saving strategies for employee healthcare

For Researchers: - Conduct in-depth studies on healthcare pricing variations - Analyze the impact of policy changes on healthcare costs - Investigate regional differences in healthcare pricing

For Policymakers: - Develop evidence-based healthcare policies - Monitor the effectiveness of price transparency initiatives - Identify areas for potential cost-saving interventions

Data Delivery

Our flexible data delivery options ensure you receive the information you need in the most convenient format:

• Custom Extracts: We can provide targeted datasets focusing on specific regions, procedures, or time periods.
• Regular Reports: Receive scheduled updates tailored to your specific requirements.

Why Choose Our Dataset?

1. Expertise: Our team has extensive experience in healthcare data retrieval and analysis, ensuring high-quality, reliable data.
2. Customization: We can tailor the dataset to meet your specific needs, whether you're interested in particular companies, regions, or procedures.
3. Scalability: Our infrastructure is designed to handle the massive scale of this dataset (400TB+ monthly), allowing us to provide comprehensive coverage without compromise.
4. Support: Our dedicated team is available to assist with data interpretation and technical support.

Harness the power of healthcare pricing transparency to drive your business forward. Contact us today to discuss how our United Healthcare Transparency in Coverage dataset can meet your specific needs and unlock valuable insights for your organization.

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains a selection of 27 indicators of public health significance by Chicago community area, with the most updated information available. The indicators are rates, percents, or other measures related to natality, mortality, infectious disease, lead poisoning, and economic status. See the full description at https://data.cityofchicago.org/api/assets/2107948F-357D-4ED7-ACC2-2E9266BBFFA2.

This table presents a wide variety of historical data in the field of health, lifestyle and health care. Figures on births and mortality, causes of death and the occurrence of certain infectious diseases are available from 1900, other series from later dates. In addition to self-perceived health, the table contains figures on infectious diseases, hospitalisations per diagnosis, life expectancy, lifestyle factors such as smoking, alcohol consumption and obesity, and causes of death. The table also gives information on several aspects of health care, such as the number of practising professionals, the number of available hospital beds, nursing day averages and the expenditures on care. Many subjects are also covered in more detail by data in other tables, although sometimes with a shorter history. Data on notifiable infectious diseases and HIV/AIDS are not included in other tables.

Data available from: 1900

Status of the figures: Most figures are definite. Figures are provisional for the last year reported for: - hospital admissions; - health professions. Figures are revised provisional for the last two years reported for: - expenditures on care. Due to "dynamic" registrations, figures for infectious diseases remain provisional.

Changes as of 29 December 2017: - For each series the most recent available figures have been added - Figures on HIV-infections have been updated over the entire range by the HIV Monitoring Foundation.

Changes as of 22 December 2016: - For each series the most recent available figures have been added - Health expenditure as percentage of bdp has been changed for 1974, 1977, 1981 and 1984.

When will new figures be published? December 2018.

The All CMS Data Feeds dataset is an expansive resource offering access to 119 unique report feeds, providing in-depth insights into various aspects of the U.S. healthcare system including nursing facility owners and accountable care organization participants contact data. With over 25.8 billion rows of data meticulously collected since 2007, this dataset is invaluable for healthcare professionals, analysts, researchers, and businesses seeking to understand and analyze healthcare trends, performance metrics, and demographic shifts over time. The dataset is updated monthly, ensuring that users always have access to the most current and relevant data available.

Dataset Overview:

118 Report Feeds: - The dataset includes a wide array of report feeds, each providing unique insights into different dimensions of healthcare. These topics range from Medicare and Medicaid service metrics, patient demographics, provider information, financial data, and much more. The breadth of information ensures that users can find relevant data for nearly any healthcare-related analysis. - As CMS releases new report feeds, they are automatically added to this dataset, keeping it current and expanding its utility for users.

25.8 Billion Rows of Data:

• With over 25.8 billion rows of data, this dataset provides a comprehensive view of the U.S. healthcare system. This extensive volume of data allows for granular analysis, enabling users to uncover insights that might be missed in smaller datasets. The data is also meticulously cleaned and aligned, ensuring accuracy and ease of use.

Historical Data Since 2007: - The dataset spans from 2007 to the present, offering a rich historical perspective that is essential for tracking long-term trends and changes in healthcare delivery, policy impacts, and patient outcomes. This historical data is particularly valuable for conducting longitudinal studies and evaluating the effects of various healthcare interventions over time.

Monthly Updates:

• To ensure that users have access to the most current information, the dataset is updated monthly. These updates include new reports as well as revisions to existing data, making the dataset a continuously evolving resource that stays relevant and accurate.

Data Sourced from CMS:

• The data in this dataset is sourced directly from the Centers for Medicare & Medicaid Services (CMS). After collection, the data is meticulously cleaned and its attributes are aligned, ensuring consistency, accuracy, and ease of use for any application. Furthermore, any new updates or releases from CMS are automatically integrated into the dataset, keeping it comprehensive and current.

Use Cases:

Market Analysis:

• The dataset is ideal for market analysts who need to understand the dynamics of the healthcare industry. The extensive historical data allows for detailed segmentation and analysis, helping users identify trends, market shifts, and growth opportunities. The comprehensive nature of the data enables users to perform in-depth analyses of specific market segments, making it a valuable tool for strategic decision-making.

Healthcare Research:

• Researchers will find the All CMS Data Feeds dataset to be a robust foundation for academic and commercial research. The historical data, combined with the breadth of coverage across various healthcare metrics, supports rigorous, in-depth analysis. Researchers can explore the effects of healthcare policies, study patient outcomes, analyze provider performance, and more, all within a single, comprehensive dataset.

Performance Tracking:

• Healthcare providers and organizations can use the dataset to track performance metrics over time. By comparing data across different periods, organizations can identify areas for improvement, monitor the effectiveness of initiatives, and ensure compliance with regulatory standards. The dataset provides the detailed, reliable data needed to track and analyze key performance indicators.

Compliance and Regulatory Reporting:

• The dataset is also an essential tool for compliance officers and those involved in regulatory reporting. With detailed data on provider performance, patient outcomes, and healthcare utilization, the dataset helps organizations meet regulatory requirements, prepare for audits, and ensure adherence to best practices. The accuracy and comprehensiveness of the data make it a trusted resource for regulatory compliance.

Data Quality and Reliability:

The All CMS Data Feeds dataset is designed with a strong emphasis on data quality and reliability. Each row of data is meticulously cleaned and aligned, ensuring that it is both accurate and consistent. This attention to detail makes the dataset a trusted resource for high-stakes applications, where data quality is critical.

Integration and Usability:

Ease of Integration:

• The dataset is provided in a CSV format, which is widely compatible with most data analysis too...

NOTE: This dataset is historical-only as of 5/10/2023. All data currently in the dataset will remain, but new data will not be added. The recommended alternative dataset for similar data beyond that date is  https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/anag-cw7u. (This is not a City of Chicago site. Please direct any questions or comments through the contact information on the site.) During the COVID-19 pandemic, the Chicago Department of Public Health (CDPH) required EMS Region XI (Chicago area) hospitals to report hospital capacity and patient impact metrics related to COVID-19 to CDPH through the statewide EMResource system. This requirement has been lifted as of May 9, 2023, in alignment with the expiration of the national and statewide COVID-19 public health emergency declarations on May 11, 2023. However, all hospitals will still be required by the U.S. Department of Health and Human Services (HHS) to report COVID-19 hospital capacity and utilization metrics into the HHS Protect system through the CDC’s National Healthcare Safety Network until April 30, 2024. Facility-level data from the HHS Protect system can be found at healthdata.gov. Until May 9, 2023, all Chicago (EMS Region XI) hospitals (n=28) were required to report bed and ventilator capacity, availability, and occupancy to the Chicago Department of Public Health (CDPH) daily. A list of reporting hospitals is included below. All data represent hospital status as of 11:59 pm for that calendar day. Counts include Chicago residents and non-residents. ICU bed counts include both adult and pediatric ICU beds. Neonatal ICU beds are not included. Capacity refers to all staffed adult and pediatric ICU beds. Availability refers to all available/vacant adult and pediatric ICU beds. Hospitals began reporting COVID-19 confirmed and suspected (PUI) cases in ICU on 03/19/2020. Hospitals began reporting ICU surge capacity as part of total capacity on 5/18/2020. Acute non-ICU bed counts include burn unit, emergency department, medical/surgery (ward), other, pediatrics (pediatric ward) and psychiatry beds. Burn beds include those approved by the American Burn Association or self-designated. Capacity refers to all staffed acute non-ICU beds. An additional 500 acute/non-ICU beds were added at the McCormick Place Treatment Facility on 4/15/2020. These beds are not included in the total capacity count. The McCormick Place Treatment Facility closed on 05/08/2020. Availability refers to all available/vacant acute non-ICU beds. Hospitals began reporting COVID-19 confirmed and suspected (PUI) cases in acute non-ICU beds on 04/03/2020. Ventilator counts prior to 04/24/2020 include all full-functioning mechanical ventilators, with ventilators with bilevel positive airway pressure (BiPAP), anesthesia machines, and portable/transport ventilators counted as surge. Beginning 04/24/2020, ventilator counts include all full-functioning mechanical ventilators, BiPAP, anesthesia machines and portable/transport ventilators. Ventilators are counted regardless of ability to staff. Hospitals began reporting COVID-19 confirmed and suspected (PUI) cases on ventilators on 03/19/2020. CDPH has access to additional ventilators from the EAMC (Emergency Asset Management Center) cache. These ventilators are included in the total capacity count. Chicago (EMS Region 11) hospitals: Advocate Illinois Masonic Medical Center, Advocate Trinity Hospital, AMITA Resurrection Medical Center Chicago, AMITA Saint Joseph Hospital Chicago, AMITA Saints Mary & Elizabeth Medical Center, Ann & Robert H Lurie Children's Hospital, Comer Children's Hospital, Community First Medical Center, Holy Cross Hospital, Jackson Park Hospital & Medical Center, John H. Stroger Jr. Hospital of Cook County, Loretto Hospital, Mercy Hospital and Medical Center, , Mount Sinai Hospital, Northwestern Memorial Hospital, Norwegian American Hospital, Roseland Community Hospital, Rush University M

The Texas Department of Insurance, Division of Workers' Compensation (DWC) maintains a database of professional medical billing services (SV1). It contains charges, payments, and treatments billed on a CMS-1500 form by doctors and other health care professionals who treat injured employees, including ambulatory surgical centers, with dates of service for the last five years. For datasets going back to 2010, see professional medical billing services (SV1) header information – historical. The header identifies insurance carriers, injured employees, employers, place of service, and diagnostic information. The bill header information groups individual line items reported in the detail section. The bill selection date and bill ID must be used to group individual line items into a single bill. Find more information in our professional medical billing services (SV1) header data dictionary. See professional medical billing services (SV1) detail information for the corresponding detail records related to this dataset. Go to our page on DWC medical state reporting public use data file (PUDF) to learn more about using this information.

The percentage of people in the United States with health insurance has increased over the past decade with a noticeably sharp increase in 2014 when the Affordable Care Act (ACA) was enacted. As of 2023, around ** percent of people in the United States had some form of health insurance, compared to around ** percent in 2010. Despite the increases in the percentage of insured people in the U.S., there were still over ** million people in the United States without health insurance as of 2023. Insurance coverage Health insurance in the United States consists of different private and public insurance programs such as those provided by private employers or those provided publicly through Medicare and Medicaid. Almost half of the insured population in the United States were insured privately through an employer as of 2021, while **** percent of people were insured through Medicaid, and **** percent through Medicare . The Affordable Care Act The Affordable Care Act (ACA), enacted in 2014, has significantly reduced the number of uninsured people in the United States. In 2014, the percentage of U.S. individuals with health insurance increased to almost ** percent. Furthermore, the percentage of people without health insurance reached an all time low in 2022. Public opinion on healthcare reform in the United States remains an ongoing political issue with public opinion consistently divided.

The article examines the participation and assistance of the Orthodox Church in solving problems that allowed to give a scientific justification for the cooperation of health care and Orthodox religious institutions, to determine their role in the historical context and structure of modern healthcare in Russia. The article presents an algorithm for organizing sisters of mercy, their system of upbringing. Particular attention is given to the possibility of teaching the course "Foundations of Orthodox Culture" in secular educational institutions. Research materials can serve as a basis for the formation of morally sound positions of medical workers and the population on the main problems of medical activity. Based on the study, the authors published a series of articles in which the experience of the work of the Orthodox Church in the charitable sphere has been summarized. This experience can be used to create new charitable institutions, including those who provided medical assistance. In preparing the article, the authors used concrete historical, civilizational, formational and social methods of research that allowed us to uncover facts, phenomena and processes in the interconnection and unity of the past, present and future.

Methods The study was conducted in the methodological field of the sociology of medicine. The research program was of a multistage nature and provided for the use of a methodology based on traditional methods of socio-hygienic, medical-organizational and historical-analytical nature, adapted to the specifics of the purposes followed by statistical processing and data analysis. In the work to achieve the goal and implement research tasks, a number of methods of concrete sociology are offered: a survey, in-depth interviews, expert interviews, content analysis, a biographical method3. The organizational chart of the interaction of Orthodox organizations and bodies of practical health, developed in this article, is based on historical traditions of the charitable activities of the Russian Orthodox Church. This scheme takes into account modern socio-economic realities. This scheme proved to be effective in the organization of medical care and can serve as a basic model for the development of cooperation between the Church and medical institutions. Given the deep historical evidence of the important role of Orthodox Christianity in preserving health and creating a healthy lifestyle for the population, it should be recognized that the development of special programs for cooperation between medical organizations and the Church is justified in modern conditions.

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains the cumulative number of deaths, average number of deaths annually, average annual crude and adjusted death rates with corresponding 95% confidence intervals, and average annual years of potential life lost per 100,000 residents aged 75 and younger due to selected causes of death, by Chicago community area, for the years 2006 – 2010. A ranking for each measure is also provided, with the highest value indicated with a ranking of 1. See the full description at: https://data.cityofchicago.org/api/views/6vw3-8p6f/files/CqPqfHSv8UUAoXCBjn4_tLqcQHhb36Ih4-meM-4zNzs?download=true&filename=P:\EPI\OEPHI\MATERIALS\REFERENCES\MORTALITY\Dataset_Description_06_10_PORTAL_ONLY.pdf

ABSTRACT This article aims to discuss the financing of Primary Care in the SUS, seeking to highlight the historical persistence of the fragility of this funding in terms of the transfer model and a limited view of the concept of Primary Care. The article is structured in three parts. The first part discusses the historical trajectory of the concept of Primary Care, from its initial radicalism in the 1960s to the 'downsizing' brought about by the new National Policy of Primary Health Care (PNAB) of 2017. The second part addresses, in a historical perspective, the federal funding of the SUS, with emphasis on Primary Care and the assessment criteria used. The third part deals with the financing of Primary Care, highlighting the resources of the Ministry of Health for this level of care, focusing on the new PNAB 2017 and, in particular, those transferred through the Basic Attention Floor (PAB) Variable.

Data on prescription drug use in the past 30 days in the United States, by sex, race and Hispanic origin, and age group. Data are from Health, United States. SOURCE: National Center for Health Statistics, National Health and Nutrition Examination Survey. Search, visualize, and download these and other estimates from over 150 health topics with the NCHS Data Query System (DQS), available from: https://www.cdc.gov/nchs/dataquery/index.htm.

Snapshot img

Population Health Management Market Size and Forecast 2025-2029

The population health management market size estimates the market to reach by USD 19.40 billion, at a CAGR of 10.7% between 2024 and 2029. North America is expected to account for 68% of the growth contribution to the global market during this period. In 2019 the software segment was valued at USD 16.04 billion and has demonstrated steady growth since then.

The market is experiencing significant growth, driven by the increasing adoption of healthcare IT and the rising focus on personalized medicine. Healthcare providers are recognizing the value of population health management platforms in improving patient outcomes and reducing costs. The implementation of these systems enables proactive care management, disease prevention, and population health analysis. However, the market faces challenges as well. The cost of installing population health management platforms can be a significant barrier for smaller healthcare organizations. Additionally, ensuring data security and interoperability across various systems remains a major concern.
Effective data management and integration are essential for population health management to deliver its full potential. Companies seeking to capitalize on market opportunities must address these challenges and provide cost-effective, secure, and interoperable solutions. By focusing on these areas, they can help healthcare providers optimize their population health management initiatives and improve patient care.

What will be the Size of the Population Health Management Market during the forecast period?

Request Free Sample

The market continues to evolve, driven by advancements in technology and a growing focus on value-based care. Risk adjustment models, which help account for the variability in health risks among patient populations, are increasingly being adopted to improve care coordination and health outcome measures. For instance, a leading healthcare organization implemented risk stratification models, resulting in a 20% reduction in hospital readmissions. Remote patient monitoring, public health surveillance, and disease outbreak response are crucial applications of population health management. These technologies enable real-time health data collection, allowing for early intervention and improved health equity initiatives. Chronic disease management, a significant focus area, benefits from electronic health records, care coordination models, and health information exchange.

Value-based care programs, predictive modeling healthcare, and telehealth platforms are transforming the landscape of healthcare delivery. Healthcare data analytics, interoperability standards, and population health dashboards facilitate data-driven decision-making, enhancing health intervention efficacy. Behavioral health integration and preventive health services are gaining prominence, with health literacy programs and clinical decision support tools supporting personalized medicine strategies. The market is expected to grow at a robust rate, with industry growth estimates reaching 15% annually. This growth is fueled by the ongoing need for healthcare cost reduction, quality improvement initiatives, and the integration of technology into healthcare delivery.

How is this Population Health Management Industry segmented?

The population health management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Software
  Services


End-user

  Large enterprises
  SMEs


Delivery Mode

  On-Premise
  Cloud-Based
  Web-Based


End-Use

  Providers
  Payers
  Employer Groups
  Government Bodies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Component Insights

The software segment is estimated to witness significant growth during the forecast period.

The market's software segment is experiencing significant growth and innovation, driven by various components that enhance healthcare organizations' capacity to manage and enhance the health outcomes of diverse populations. Population health management platforms aggregate and integrate data from multiple sources, including electronic health records, claims data, and patient-generated data. Advanced analytics are employed to generate valuable insights, enabling healthcare providers to identify at-risk populations, address chronic conditions, and improve overall patient outcomes. These platforms facilitate seamless data exchange between stakeholders, ensuring harmonious care coordination and enhancing the overall effectiveness of healthcare services.

Request Free Sample

[207+ Pages Report] The global Medical Device Security Market size was valued at USD 725.10 million in 2021 and is estimated to reach USD 1,493.66 million by 2028, at a CAGR value of 12.80% from 2022 to 2028.

The Global Patient Engagement Technology Market Size Was Worth $6,000 Million in 2022 and Is Expected To Reach $9,000 Million by 2030, CAGR of 7.0%.

Note: After May 3, 2024, this dataset will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, hospital capacity, or occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The related CDC COVID Data Tracker site was revised or retired on May 10, 2023.

Note: May 3,2024: Due to incomplete or missing hospital data received for the April 21,2024 through April 27, 2024 reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on May 3, 2024.

This dataset represents COVID-19 hospitalization data and metrics aggregated to county or county-equivalent, for all counties or county-equivalents (including territories) in the United States as of the initial date of reporting for each weekly metric. COVID-19 hospitalization data are reported to CDC’s National Healthcare Safety Network, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN and included in this dataset represent aggregated counts and include metrics capturing information specific to COVID-19 hospital admissions, and inpatient and ICU bed capacity occupancy.

Reporting information:

• As of December 15, 2022, COVID-19 hospital data are required to be reported to NHSN, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN represent aggregated counts and include metrics capturing information specific to hospital capacity, occupancy, hospitalizations, and admissions. Prior to December 15, 2022, hospitals reported data directly to the U.S. Department of Health and Human Services (HHS) or via a state submission for collection in the HHS Unified Hospital Data Surveillance System (UHDSS).
• While CDC reviews these data for errors and corrects those found, some reporting errors might still exist within the data. To minimize errors and inconsistencies in data reported, CDC removes outliers before calculating the metrics. CDC and partners work with reporters to correct these errors and update the data in subsequent weeks.
• Many hospital subtypes, including acute care and critical access hospitals, as well as Veterans Administration, Defense Health Agency, and Indian Health Service hospitals, are included in the metric calculations provided in this report. Psychiatric, rehabilitation, and religious non-medical hospital types are excluded from calculations.
• Data are aggregated and displayed for hospitals with the same Centers for Medicare and Medicaid Services (CMS) Certification Number (CCN), which are assigned by CMS to counties based on the CMS Provider of Services files.
• Full details on COVID-19 hospital data reporting guidance can be found here: https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf

• County-level hospital data are derived using calculations performed at the Health Service Area (HSA) level. An HSA is defined by CDC’s National Center for Health Statistics as a geographic area containing at least one county which is self-contained with respect to the population’s provision of routine hospital care. Every county in the United States is assigned to an HSA, and each HSA must contain at least one hospital. Therefore, use of HSAs in the calculation of local hospital metrics allows for more accurate characterization of the relationship between health care utilization and health status at the local level.
• Data presented at the county-level represent admissions, hospital inpatient and ICU bed capacity and occupancy among hospitals within the selected HSA. Therefore, admissions, capacity, and occupancy are not limited to residents of the selected HSA.
• For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.
• For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.

• Time period: data for the previous MMWR week (Sunday-Saturday) will update weekly on Mondays as soon as they are reviewed and verified, usually before 8 pm ET. Updates will occur the following day when reporting coincides with a federal holiday. Note: Weekly updates might be delayed due to delays in reporting. All data are provisional. Because these provisional counts are subject to change, including updates to data reported previously, adjustments can occur. Data may be updated since original publication due to delays in reporting (to account for data received after a given Thursday publication) or data quality corrections.
• New hospital admissions (count): Total number of admissions of patients with laboratory-confirmed COVID-19 in the previous week (including both adult and pediatric admissions) in the entire jurisdiction
• New Hospital Admissions Rate Value (Admissions per 100k): Total number of new admissions of patients with laboratory-confirmed COVID-19 in the past week (including both adult and pediatric admissions) for the entire jurisdiction divided by 2019 intercensal population estimate for that jurisdiction multiplied by 100,000. (Note: This metric is used to determine each county’s COVID-19 Hospital Admissions Level for a given week).
• New COVID-19 Hospital Admissions Rate Level: qualitative value of new COVID-19 hospital admissions rate level [Low, Medium, High, Insufficient Data]
• New hospital admissions percent change from prior week: Percent change in the current weekly total new admissions of patients with laboratory-confirmed COVID-19 per 100,000 population compared with the prior week.
• New hospital admissions percent change from prior week level: Qualitative value of percent change in hospital admissions rate from prior week [Substantial decrease, Moderate decrease, Stable, Moderate increase, Substantial increase, Insufficient data]
• COVID-19 Inpatient Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 (including both adult and pediatric patients) within the in the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (patients hospitalized with confirmed COVID-19) and denominators (staffed inpatient beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction.
• COVID-19 Inpatient Bed Occupancy Level: Qualitative value of inpatient beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data]
• COVID-19 Inpatient Bed Occupancy percent change from prior week: The absolute change in the percent of staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed inpatient beds in the past week, compared with the prior week, in the entire jurisdiction.
• COVID-19 ICU Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by adult patients with confirmed COVID-19 within the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (adult patients hospitalized with confirmed COVID-19) and denominators (staffed adult ICU beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction.
• COVID-19 ICU Bed Occupancy Level: Qualitative value of ICU beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data]
• COVID-19 ICU Bed Occupancy percent change from prior week: The absolute change in the percent of staffed ICU beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed adult ICU beds for the past week, compared with the prior week, in the in the entire jurisdiction.
• For all metrics, if there are no data in the specified locality for a given week, the metric value is displayed as “insufficient data”.

Notes: June 15, 2023: Due to incomplete or missing hospital data received for the June 4, 2023, through June 10, 2023, reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and AS and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on June 15, 2023.

July 10, 2023: Due to incomplete or missing hospital data received for the June 25, 2023, through July 1, 2023, reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and AS and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on July 10, 2023.

July 17, 2023: Due to incomplete or missing hospital data received for the July 2, 2023, through July 8, 2023, reporting